Phase 2 Study of Velusetrag in Diabetic or Idiopathic Gastroparesis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01718938
Recruitment Status : Completed
First Posted : November 1, 2012
Last Update Posted : February 26, 2018
Alfasigma S.p.A.
Information provided by (Responsible Party):
Theravance Biopharma R & D, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2013
  Actual Study Completion Date : February 2014
  Certification/Extension First Submitted : February 22, 2018